SCHEMBL12952918

SCHEMBL12952918

NC(=O)c1nc2ccc(N3CCOCC3)cn2c(=O)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.46
LRRK2 Q5S007 5/20 0.42
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PIK3CD O00329 1/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 1/20 0.41
PRKDC P78527 1/20 0.40
CSF1R P07333 1/20 0.40
PDGFRA P16234 1/20 0.40
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
CCNA1 P78396 1/20 0.39
HTT P42858 1/20 0.39
PARP1 P09874 1/20 0.38
JAK2 O60674 2/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823327 0.85 MAPT (0.48) SLC2A1ALDH1A1L3MBTL1PIK3CAKDM4E
SCHEMBL12894055 0.80 MAPT (0.44) SLC2A1LRRK2ALDH1A1L3MBTL1KDM4E
SCHEMBL823396 0.80 L3MBTL1 (0.47) ALDH1A1L3MBTL1KDM4EMAPTHTT
SCHEMBL1221906 0.79 MEN1 (0.42) SLC2A1LRRK2ALDH1A1L3MBTL1PIK3CB
SCHEMBL823395 0.78 CYP2C9 (0.51) ALDH1A1KDM4EHTTHPGDSMN1; SMN2
SCHEMBL823378 0.78 SLC2A1 (0.52) SLC2A1ALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL823367 0.77 RXFP1 (0.50) SLC2A1ALDH1A1PIK3CAPIK3CBPIK3CG
SCHEMBL823382 0.77 ERCC1 (0.45) SLC2A1MAPTHTT
SCHEMBL823331 0.76 THRB (0.51) ALDH1A1KDM4EMAPTHTTCYP1A2
SCHEMBL12166740 0.74 CSNK1D (0.43) SLC2A1ALDH1A1KDM4EMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2269992-A1 Bicyclic pyrimidinones for the treatment of viral infections Avexa Limited (AU) 2011-01-05 EP disclosed